These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26464312)

  • 1. Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen.
    Gattringer M; Baranyi U; Pilat N; Hock K; Klaus C; Ramsey HE; Wrba F; Valenta R; Wekerle T
    Clin Exp Allergy; 2016 Feb; 46(2):354-64. PubMed ID: 26464312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy.
    Linhart B; Bigenzahn S; Hartl A; Lupinek C; Thalhamer J; Valenta R; Wekerle T
    J Immunol; 2007 Mar; 178(6):3924-31. PubMed ID: 17339493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination blockade of OX40L and CD30L inhibits allergen-driven memory T
    Gracias DT; Sethi GS; Mehta AK; Miki H; Gupta RK; Yagita H; Croft M
    J Allergy Clin Immunol; 2021 Jun; 147(6):2316-2329. PubMed ID: 33160971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
    Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
    PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcεRI or FcαRI on mast cells in mouse allergic asthma.
    Hong GU; Lim JY; Kim NG; Shin JH; Ro JY
    Eur J Pharmacol; 2015 May; 754():199-210. PubMed ID: 25704619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined costimulation blockade inhibits accelerated rejection mediated by alloantigen-primed memory T cells in mice.
    Xie B; Chen J; Xia J; Wang Y; Liang H; Ekberg H; Corbascio M; Qi Z
    Immunol Invest; 2009; 38(7):639-51. PubMed ID: 19811427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
    Honkanen-Scott M; Johnson J; Hering B; Bansal-Pakala P
    Transplant Proc; 2008 Mar; 40(2):483-5. PubMed ID: 18374109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunoglobulin E responses in Balb/c mice against the major allergens of timothy grass (Phleum pratense) pollen.
    Seitzer U; Bussler H; Kullmann B; Petersen A; Becker WM; Ahmed J
    Clin Exp Allergy; 2003 May; 33(5):669-75. PubMed ID: 12752597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.
    Qaseem AS; Singh I; Pathan AA; Layhadi JA; Parkin R; Alexandra F; Durham SR; Kishore U; Shamji MH
    Am J Respir Crit Care Med; 2017 Dec; 196(12):1526-1534. PubMed ID: 28915062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ; Hirschfield GM; Lane PJ
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand.
    Tang A; Judge TA; Nickoloff BJ; Turka LA
    J Immunol; 1996 Jul; 157(1):117-25. PubMed ID: 8683104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways.
    Li DQ; Zhang L; Pflugfelder SC; De Paiva CS; Zhang X; Zhao G; Zheng X; Su Z; Qu Y
    J Allergy Clin Immunol; 2011 Dec; 128(6):1318-1325.e2. PubMed ID: 21820713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
    Gauvreau GM; Boulet LP; Cockcroft DW; FitzGerald JM; Mayers I; Carlsten C; Laviolette M; Killian KJ; Davis BE; Larché M; Kipling C; Dua B; Mosesova S; Putnam W; Zheng Y; Scheerens H; McClintock D; Matthews JG; O'Byrne PM
    Clin Exp Allergy; 2014 Jan; 44(1):29-37. PubMed ID: 24224471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.
    Baranyi U; Farkas AM; Hock K; Mahr B; Linhart B; Gattringer M; Focke-Tejkl M; Petersen A; Wrba F; Rülicke T; Valenta R; Wekerle T
    EBioMedicine; 2016 May; 7():230-9. PubMed ID: 27322476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.
    Shin CA; Cho HW; Shin AR; Sohn HJ; Cho HI; Kim TG
    Oncotarget; 2016 Jul; 7(29):46173-46186. PubMed ID: 27323820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
    Seshasayee D; Lee WP; Zhou M; Shu J; Suto E; Zhang J; Diehl L; Austin CD; Meng YG; Tan M; Bullens SL; Seeber S; Fuentes ME; Labrijn AF; Graus YM; Miller LA; Schelegle ES; Hyde DM; Wu LC; Hymowitz SG; Martin F
    J Clin Invest; 2007 Dec; 117(12):3868-78. PubMed ID: 18060034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.